Martínez C - Search Results

1

Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.

García-Martín E, Martínez C, Ladero JM, Agúndez JA. García-Martín E, et al. Among authors: martinez c. Mol Diagn Ther. 2006;10(1):29-40. doi: 10.1007/BF03256440. Mol Diagn Ther. 2006. PMID: 16646575 Review.

2

Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk.

García-Martín E, Martínez C, Ladero JM, Gamito FJ, Rodriguez-Lescure A, Agúndez JA. García-Martín E, et al. Among authors: martinez c. Cancer Lett. 2002 Jun 6;180(1):41-6. doi: 10.1016/s0304-3835(02)00015-0. Cancer Lett. 2002. PMID: 11911968

3

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use.

Martínez C, Blanco G, Ladero JM, García-Martín E, Taxonera C, Gamito FG, Diaz-Rubio M, Agúndez JA. Martínez C, et al. Br J Pharmacol. 2004 Jan;141(2):205-8. doi: 10.1038/sj.bjp.0705623. Epub 2004 Jan 5. Br J Pharmacol. 2004. PMID: 14707031 Free PMC article.

4

Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms.

García-Martín E, Martínez C, Tabarés B, Frías J, Agúndez JA. García-Martín E, et al. Among authors: martinez c. Clin Pharmacol Ther. 2004 Aug;76(2):119-27. doi: 10.1016/j.clpt.2004.04.006. Clin Pharmacol Ther. 2004. PMID: 15289789

5

The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.

Martínez C, García-Martín E, Blanco G, Gamito FJ, Ladero JM, Agúndez JA. Martínez C, et al. Br J Clin Pharmacol. 2005 Jan;59(1):62-9. doi: 10.1111/j.1365-2125.2004.02183.x. Br J Clin Pharmacol. 2005. PMID: 15606441 Free PMC article.

6

Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.

García-Martín E, Pizarro RM, Martínez C, Gutierrez-Martín Y, Pérez G, Jover R, Agúndez JA. García-Martín E, et al. Among authors: martinez c. Pharmacogenomics. 2006 Jun;7(4):575-85. doi: 10.2217/14622416.7.4.575. Pharmacogenomics. 2006. PMID: 16753005

7

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.

Gervasini G, García-Martín E, Ladero JM, Pizarro R, Sastre J, Martínez C, García M, Diaz-Rubio M, Agúndez JA. Gervasini G, et al. Among authors: martinez c. BMC Cancer. 2007 Jul 2;7:118. doi: 10.1186/1471-2407-7-118. BMC Cancer. 2007. PMID: 17605821 Free PMC article.

8

Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor.

Martínez C, García-Martín E, Alonso-Navarro H, Jiménez-Jiménez FJ, Benito-León J, García-Ferrer I, Vázquez-Torres P, Puertas I, Zurdo JM, López-Alburquerque T, Agúndez JA. Martínez C, et al. Neuromolecular Med. 2007;9(2):195-204. doi: 10.1007/BF02685892. Neuromolecular Med. 2007. PMID: 17627038

9

Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity.

Ayuso P, García-Martín E, Martínez C, Agúndez JA. Ayuso P, et al. Among authors: martinez c. Pharmacogenet Genomics. 2007 Sep;17(9):687-93. doi: 10.1097/FPC.0b013e328012b8e4. Pharmacogenet Genomics. 2007. PMID: 17700358

10

Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding.

Blanco G, Martínez C, Ladero JM, Garcia-Martin E, Taxonera C, Gamito FG, Diaz-Rubio M, Agundez JA. Blanco G, et al. Among authors: martinez c. Pharmacogenet Genomics. 2008 Jan;18(1):37-43. doi: 10.1097/FPC.0b013e3282f305a9. Pharmacogenet Genomics. 2008. PMID: 18216720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,089 results

Search Page